Log in to search using one of your social media accounts:

 

HPV jab means women ‘only need three smears in lifetime’
Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine, according to UK researchers. (Source: Nursing Times)
Source: Nursing Times - November 10, 2017 Category: Nursing Source Type: news

HPV Vaccine May Prevent Rare Childhood Disease
The human papillomavirus (HPV) vaccine, first developed to help guard against cervical cancer, also seems to protect against a rare, chronic childhood respiratory disease. (Source: WebMD Health)
Source: WebMD Health - November 9, 2017 Category: Consumer Health News Source Type: news

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
Funding for research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. (Source: PHPartners.org)
Source: PHPartners.org - November 9, 2017 Category: International Medicine & Public Health Source Type: news

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
Funding for research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. (Source: PHPartners.org)
Source: PHPartners.org - November 9, 2017 Category: International Medicine & Public Health Source Type: news

HPV Vaccine Linked to Drop in Cases of Rare Childhood Disease
THURSDAY, Nov. 9, 2017 -- The human papillomavirus (HPV) vaccine, first developed to help guard against cervical cancer, also seems to protect against a rare, chronic childhood respiratory disease, a new study suggests. It's believed that the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 9, 2017 Category: General Medicine Source Type: news

HPV vaccine also prevents uncommon childhood respiratory disease, study suggests
(Infectious Diseases Society of America) The vaccine that protects against cancer-causing types of human papillomavirus (HPV) also prevents an uncommon but incurable childhood respiratory disease, according to a new study published in The Journal of Infectious Diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 9, 2017 Category: Cancer & Oncology Source Type: news

HPV jab means women only need 3 cervical screens in a lifetime
(Cancer Research UK) Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine, according to a new study published in the International Journal of Cancer today. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 9, 2017 Category: Cancer & Oncology Source Type: news

Survival With HPV-related Cancers Varies by Race, Sex and Age Survival With HPV-related Cancers Varies by Race, Sex and Age
Survival with human papillomavirus (HPV)-associated cancers differs significantly between blacks and whites, men and women, and people in different age groups, according to findings from the Centers for Disease Control and Prevention (CDC) National Program of Cancer Registries (NPCR).Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

IUD May Lower Cervical Cancer Risk
TUESDAY, Nov. 7, 2017 -- IUD contraceptive devices may reduce a woman's risk of cervical cancer by about a third, a new review concludes. Researchers think IUDs might promote an immune response that kills off human papillomavirus (HPV), the virus... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 7, 2017 Category: General Medicine Source Type: news

Study reveals large disparities in survival for patients with HPV-associated cancers
(Wiley) A new study found large disparities by sex, race, and age in survival for patients diagnosed with different cancers caused by the human papillomavirus (HPV). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 6, 2017 Category: International Medicine & Public Health Source Type: news

Clarivate Analytics & Chinese Academy of Sciences announce annual report identifying 100 hottest and 43 emerging areas in global scientific research
This report reveals that based on the 143 Research Fronts, the USA is still leading global research followed by China in second place ahead of the UK and Germany. China is most prolific in chemistry, materials science, mathematics, computer science and engineering, and is leading the rest of the world in terms of research in mathematics, computer science and engineering. Twenty noteworthy topics among the 100 hottest Research Fronts are: Hot Research Fronts Field of Science Research on genome editing in plants and the utility in crops Agricultural, Plant and Animal Sciences Regulation mechan...
Source: News from STM - November 2, 2017 Category: Databases & Libraries Authors: STM Publishing News Tags: Featured World Source Type: news

HIV Guidelines Make Special HPV Recommendations for Gay Men HIV Guidelines Make Special HPV Recommendations for Gay Men
New European guidelines differ from American guidelines in that they recommend that gay and bisexual men get vaccinated for human papillomavirus until age 40.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2017 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

For college men, low awareness of HPV risk -- Education may help increase vaccination rate
(Wolters Kluwer Health) Male collegiate athletes have high rates of risk factors for infection with the cancer-causing human papillomavirus (HPV), but have low HPV vaccination rates and low awareness of their personal health risks, according to a study in the November issue of The Nurse Practitioner, published by Wolters Kluwer. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 26, 2017 Category: Infectious Diseases Source Type: news

Medical News Today: Head and neck cancer: Could oral sex raise your risk?
Researchers have found a link between oral sex and smoking and an increased risk of a type head and neck cancer triggered by the human papillomavirus. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 21, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Men who perform oral sex on women 'more at risk of mouth and throat cancers'
Conclusion This study uses a large amount of national data to give us an idea about which groups of people have the greatest risk of carrying potentially cancer-causing oral HPV . But while oral HPV may increase people's risk of mouth and throat cancers, the actual number who would go on to develop cancer is extremely small. This study has limitations, which are worth bearing in mind: It only looked at whether people had oral HPV at a single point in time. This makes it difficult to know at what point they became infected and how much this could be down to other risk factors such as smoking, oral sex and number of partne...
Source: NHS News Feed - October 20, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Oral Sex Plus Smoking a Cancer Danger for Men
FRIDAY, Oct. 20, 2017 -- Smoking and oral sex may be a deadly combo that raises a man's risk for head and neck cancer, a new study suggests. The key factor is transmission of oral strains of the cancer-linked human papillomavirus (HPV), which can... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 20, 2017 Category: General Medicine Source Type: news

New study finds HPV vaccine to be safe for adult women
Although most human papillomavirus prevention efforts are targeted toward adolescents, a new study found the HPV vaccine is safe for adult women. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 19, 2017 Category: Consumer Health News Source Type: news

7 Million American Men Carry Cancer-Causing HPV
The incidence of mouth and throat cancers caused by the human papillomavirus in men has now surpassed the incidence of HPV-related cervical cancers in women. (Source: NYT Health)
Source: NYT Health - October 18, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Head and Neck Cancer Human Papillomavirus (HPV) Sexually Transmitted Diseases Throat Smoking and Tobacco Men and Boys Vaccination and Immunization Infections Source Type: news

Novan leans on its spinout, Know Bio, to bolster acne drug pipeline
Morrisville-based Novan (Nasdaq: NOVN) is broadening its focus through acquiring new intellectual property rights and is closing in on a deal to move its acne product forward. Through a deal with Know Bio – which was spun out from Novan prior to Novan’s IPO last year – Novan has acquired the exclusive worldwide rights to applications of nitric-oxide-based products for the treatment of cancer-causing viruses. Those viruses include human papillomavirus (HPV)-associa ted sexually transmitted infections. Novan… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 18, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Novan leans on its spinout, Know Bio, to bolster acne drug pipeline
Morrisville-based Novan (Nasdaq: NOVN) is broadening its focus through acquiring new intellectual property rights and is closing in on a deal to move its acne product forward. Through a deal with Know Bio – which was spun out from Novan prior to Novan’s IPO last year – Novan has acquired the exclusive worldwide rights to applications of nitric-oxide-based products for the treatment of cancer-causing viruses. Those viruses include human papillomavirus (HPV)-associa ted sexually transmitted infections. Novan… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 18, 2017 Category: American Health Authors: Jennifer Henderson Source Type: news

HPV Vaccine Safe for Adult Women: Study
WEDNESDAY, Oct. 18, 2017 -- Vaccines that ward off the cancer-linked human papillomavirus (HPV) are safe for adult women, according to a study of more than 3 million Scandinavians. The researchers, who used Danish and Swedish hospital data to track... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 18, 2017 Category: General Medicine Source Type: news

Is HPV vaccination safe for adult women?
(Wiley) In a Journal of Internal Medicine study of more than 3 million Danish and Swedish adult women, human papillomavirus (HPV) vaccination was not linked with 44 serious chronic diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 18, 2017 Category: International Medicine & Public Health Source Type: news

1 in 9 American men infected with oral HPV
Eleven million American men are infected with oral human papillomavirus (HPV), which can lead to cancers of the head, neck and throat, a new study reports. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 17, 2017 Category: Consumer Health News Source Type: news

1 in 9 U.S. Men Have Oral HPV Infection (FREE)
By Amy Orciari Herman Edited by Jaye Elizabeth Hefner, MD Nearly 12% of U.S. men are infected with oral human papillomavirus (HPV), according to an Annals of Internal Medicine study. The prevalence among women is much lower, at 3%. … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 17, 2017 Category: Primary Care Source Type: news

One in nine American men has oral HPV, study finds
About one in nine American men is infected with the oral form of human papillomavirus (HPV), according to a new study published in the journal Annals of Internal Medicine. Nationwide, rates for oral HPV infections are 11.5% of men and 3.2% of women: 11 million men, compared with 3.2 million women, the researchers estimated. (Source: CNN.com - Health)
Source: CNN.com - Health - October 16, 2017 Category: Consumer Health News Source Type: news

More men than women infected with oral human papillomavirus
(Reuters Health) - Roughly one in nine U.S. men have oral infections of the cancer-causing human papillomavirus (HPV), more than triple the infection rate for women, a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - October 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

7 Million American Men Carry Cancer-Causing HPV Virus
The incidence of mouth and throat cancers caused by the human papilloma virus in men has now surpassed the incidence of HPV-related cervical cancers in women. (Source: NYT Health)
Source: NYT Health - October 16, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Head and Neck Cancer Human Papillomavirus (HPV) Sexually Transmitted Diseases Throat Smoking and Tobacco Men and Boys Vaccination and Immunization Infections Source Type: news

1 in 9 American Men Infected With Oral HPV
MONDAY, Oct. 16, 2017 -- Eleven million American men are infected with oral human papillomavirus (HPV), which can lead to cancers of the head, neck and throat, a new study reports. That equates to 1 in 9 U.S. males aged 18 to 69. And infection is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 16, 2017 Category: General Medicine Source Type: news

Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015
Study assessed efforts among Wisconsin stakeholders in HPV vaccination and organizational capacity for future collaborative work. (Source: PHPartners.org)
Source: PHPartners.org - October 6, 2017 Category: International Medicine & Public Health Source Type: news

Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - October 5, 2017 Category: International Medicine & Public Health Source Type: news

HPV blood test: Throat CANCER chemotherapy treatment can cause THESE toxic side-effects
A TEST for throat cancer patients with the human papillomavirus could find whether chemotherapy treatment will be effective. (Source: Daily Express - Health)
Source: Daily Express - Health - October 5, 2017 Category: Consumer Health News Source Type: news

HPV blood test: Throat cancer treatment can cause THESE toxic side-effects
A TEST for throat cancer patients with the human papillomavirus could find whether chemotherapy treatment will be effective. (Source: Daily Express - Health)
Source: Daily Express - Health - October 5, 2017 Category: Consumer Health News Source Type: news

By decoding how HPV causes cancer, researchers find a new potential treatment strategy
(Georgetown University Medical Center) A study that teases apart the biological mechanisms by which human papillomaviruses (HPV) cause cancer has found what researchers at Georgetown University Medical Center say is a new strategy that might provide targeted treatment for these cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 2, 2017 Category: Cancer & Oncology Source Type: news

Take a Number: The HPV Vaccine Gains Ground Among U.S. Teenagers
Sixty percent of adolescents received the vaccine in 2016. A decade ago, less than 30 percent did. (Source: NYT Health)
Source: NYT Health - September 22, 2017 Category: Consumer Health News Authors: ANERI PATTANI Tags: Human Papillomavirus (HPV) Vaccination and Immunization Centers for Disease Control and Prevention Teenagers and Adolescence Source Type: news

Transgene starts dosing in Phase Ib/II combination trial for HPV-positive cancers
Transgene has started dosing patients in a Phase Ib/II clinical trial of TG4001 in combination with avelumab to treat human papillomavirus type 16 positive (HPV-16+) recurrent or metastatic cancers. (Source: Drug Development Technology)
Source: Drug Development Technology - September 20, 2017 Category: Pharmaceuticals Source Type: news

Primary HPV Screening Detects More Lesions Than Cytology in Vaccinated Population (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Human papillomavirus (HPV) screening — compared with cytology-based screening — is associated with higher detection rates for precancerous cervical … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 20, 2017 Category: Primary Care Source Type: news

Screening for cervical abnormalities in women offered HPV vaccination
(PLOS) Human papillomavirus (HPV) testing detects a higher number of precancerous cervical lesions than cytology-based Pap smears in a female population including a proportion offered HPV vaccination, according to a new study published in PLOS Medicine by Karen Canfell of Cancer Council New South Wales, Australia, researchers at the Victorian Cytology Service, Melbourne, Australia, and colleagues. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 19, 2017 Category: Cancer & Oncology Source Type: news

BU: HPV vaccine associated with improved fertility in some women
(Boston University School of Medicine) More than 40 percent of American teens are now getting vaccinated against human papillomavirus (HPV). But, despite HPV infection being associated with reduced semen quality and lower pregnancy rates, there is still public concern about whether the HPV vaccine itself could affect future fertility. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 19, 2017 Category: International Medicine & Public Health Source Type: news

Herd Immunity to HPV Emerging Among Young Women in the U.S. Herd Immunity to HPV Emerging Among Young Women in the U.S.
Human papillomavirus (HPV) infection is declining among young U.S. women, including those who have not received the vaccine, according to new research.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 13, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

USPSTF Draft Recommendation Eliminates Cervical Cytology-HPV Cotesting for Women Over 30 (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Women aged 30 –65 should undergo cervical cancer screening with either cervical cytology alone every 3 years or high-risk human papillomavirus … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 12, 2017 Category: Primary Care Source Type: news

HPV vaccine may even protect women who never received it: Study
Fewer adult women are becoming infected with human papillomavirus, a trend that includes females who have never received the HPV vaccine, a new study reports. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 8, 2017 Category: Consumer Health News Source Type: news

HPV Vaccine May Even Protect Women Who Never Got It
FRIDAY, Sept. 8, 2017 -- Fewer adult women are becoming infected with human papillomavirus (HPV), a trend that includes females who have never received the HPV vaccine, a new study reports. It appears that enough women have gotten the HPV vaccine... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 8, 2017 Category: General Medicine Source Type: news

Improving cervical cancer screening rates for transgender men
(Mary Ann Liebert, Inc./Genetic Engineering News) A new study indicates that alternative options for cervical cancer screening, including self-sampling for human papillomavirus (HPV) testing, could improve the screening rate among transgender men. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news

World Trade Center responders might face greater risk of HPV throat and tongue cancer
(Rutgers University) Researchers at Rutgers University -- investigating the causes of head and neck cancers in World Trade Center rescue and recovery workers -- will take the lead in a study to determine whether the responders are at a greater risk for human papillomavirus (HPV)-related throat and tongue cancer because of their exposure to toxic dust and debris. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news

Human papillomavirus 16 infections may pose variable cancer risk
(Cell Press) Human papillomavirus 16 accounts for about half of all cervical cancers, but researchers reporting Sept. 7 in the journal Cell have found that not all infections are equal. An analysis of the HPV16 genome from 5,570 human cell and tissue samples revealed that the virus actually consists of thousands of unique genomes, such that infected women living in the same region often have different HPV16 sequences and variable risks to cancer. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 7, 2017 Category: Infectious Diseases Source Type: news

NAS, NAM Members Receive Lasker Awards
The Albert and Mary Lasker Foundation announced today that NAS member Michael N. Hall, professor, Biozentrum, University of Basel, Switzerland, is the recipient of the 2017 Albert Lasker Basic Medical Research Award for"discoveries concerning the nutrient-activated TOR proteins and their central role in the metabolic control of cell growth." Dual NAS/NAM member Douglas Lowy, acting director of the National Cancer Institute, has been awarded the 2017 Lasker~DeBakey Clinical Medical Research Award, along with John T. Schiller of the NCI, for"technological advances that enabled development of HPV vaccines for p...
Source: News from the National Academies - September 6, 2017 Category: Science Source Type: news

3 Scientists and Planned Parenthood Win Lasker Prizes for Medical Research
(NEW YORK) — Two scientists who paved the way for widely used vaccines and another who discovered key players in cell growth have been awarded prestigious medical research awards. The Albert and Mary Lasker Foundation also announced Wednesday that it was giving its public service award to Planned Parenthood. Each award includes a $250,000 honorarium. The foundation’s clinical research award is shared by Dr. Douglas Lowy and John Schiller of the U.S. National Cancer Institute. In the early 1990s they began work that would eventually lead to vaccines against human papillomavirus, or HPV, which causes cervical can...
Source: TIME.com: Top Science and Health Stories - September 6, 2017 Category: Consumer Health News Authors: Malcolm Ritter / AP Tags: Uncategorized awards medical research onetime Planned Parenthood Science Source Type: news

Lasker Prizes go to Planned Parenthood and Developers of HPV Vaccine
Prestigious awards come during a time of uncertainty for reproductive health care in the United States (Source: NYT Health)
Source: NYT Health - September 6, 2017 Category: Consumer Health News Authors: HEATHER MURPHY Tags: Lasker Awards Human Papillomavirus (HPV) Planned Parenthood Federation of America Lasker, Albert and Mary, Foundation Source Type: news

New study finds improved vaccine that protects against nine types of HPV
(H. Lee Moffitt Cancer Center& Research Institute) Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly reduced the number of those who develop and die from cervical cancer. And thanks to an international effort to improve the vaccine, the medical community is one step closer to preventing more HPV-associated diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 6, 2017 Category: Cancer & Oncology Source Type: news

$1.8 million granted to YSPH to study effectiveness of HPV vaccine
A $1.8 million National Institutes of Health grant will help Yale researchers shed light on the real-world effectiveness of the Human Papillomavirus vaccine. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 5, 2017 Category: Universities & Medical Training Source Type: news